Complete Filing Data
Nuvalent, Inc. reported Net Income Loss of -$425.38 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Nuvalent, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$425.4M | -$260.8M | -$126.2M | -$81.9M | -$46.3M | -$14.6M |
| Research And Development Expense | $307.0M | $217.8M | $113.2M | $63.7M | $35.6M | $15.4M |
| Operating Income Loss | -$414.3M | -$280.4M | -$149.5M | -$86.1M | -$45.8M | -$16.9M |
| Operating Expenses | $414.3M | $280.4M | $149.5M | $86.1M | $45.8M | $16.9M |
| Nonoperating Income Expense | -$10.5M | $20.4M | $23.3M | $4.3M | -$521.0K | $2.3M |
| General And Administrative Expense | $107.3M | $62.6M | $36.2M | $22.4M | $10.3M | $1.5M |
| Comprehensive Income Net Of Tax | -$423.0M | -$260.8M | -$125.7M | -$82.1M | -$46.6M | -$14.6M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $2.4M | -$90.0K | $525.0K | -$266.0K | -$228.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$424.8M | -$260.0M | -$126.2M | -$81.9M | ||
| Income Tax Expense Benefit | $585.0K | $764.0K | $0.00 | $0.00 | ||
| Other Nonoperating Income Expense | $114.0K | -$35.0K | ||||
| Related Party Revenue Share Liability | $73.2M | $17.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$122.4M | -$99.7M | -$84.6M | -$84.3M | -$57.2M | -$44.5M | -$33.6M | -$29.1M | -$25.2M | -$19.7M | -$18.5M | -$17.5M | -$12.4M | -$9.8M | -$6.8M | -$4.8M | -$8.6M | $5.4M |
| Research And Development Expense | $83.8M | $80.9M | $74.4M | $60.6M | $49.2M | $38.6M | $29.6M | $25.9M | $22.1M | $14.6M | $13.6M | $12.7M | $9.1M | $7.8M | $5.5M | $3.7M | $3.7M | |
| Operating Income Loss | -$112.7M | -$104.6M | -$94.8M | -$76.3M | -$65.2M | -$52.6M | -$38.8M | -$34.1M | -$30.2M | -$20.4M | -$18.7M | -$17.7M | -$12.4M | -$9.9M | -$6.2M | -$4.0M | -$4.0M | |
| Operating Expenses | $112.7M | $104.6M | $94.8M | $76.3M | $65.2M | $52.6M | $38.8M | $34.1M | $30.2M | $20.4M | $18.7M | $17.7M | $12.4M | $9.9M | $6.2M | $4.0M | $4.0M | |
| Nonoperating Income Expense | -$9.6M | $5.1M | $10.4M | -$8.0M | $8.2M | $8.5M | $5.1M | $5.0M | $5.0M | $672.0K | $267.0K | $139.0K | $1.0K | $12.0K | -$623.0K | -$738.0K | -$4.6M | |
| General And Administrative Expense | $28.9M | $23.7M | $20.4M | $15.8M | $16.0M | $14.0M | $9.2M | $8.1M | $8.1M | $5.8M | $5.2M | $5.0M | $3.4M | $2.0M | $678.0K | $319.0K | $349.0K | |
| Comprehensive Income Net Of Tax | -$121.4M | -$99.1M | -$83.7M | -$81.4M | -$57.4M | -$45.8M | -$33.4M | -$30.3M | -$25.0M | -$19.5M | -$18.6M | -$18.3M | -$12.4M | -$9.8M | -$6.8M | -$4.8M | ||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $1.0M | $509.0K | $913.0K | $2.9M | -$253.0K | -$1.3M | $227.0K | -$1.2M | $192.0K | $266.0K | -$113.0K | -$791.0K | -$23.0K | $0.00 | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$122.3M | -$99.5M | -$84.4M | -$84.3M | -$57.0M | -$44.1M | -$33.6M | -$29.1M | -$25.2M | |||||||||
| Income Tax Expense Benefit | $132.0K | $145.0K | $157.0K | $40.0K | $170.0K | $383.0K | $0.00 | |||||||||||
| Other Nonoperating Income Expense | $672.0K | $267.0K | $139.0K | $1.0K | $12.0K | $12.0K | -$14.0K | -$9.0K | ||||||||||
| Related Party Revenue Share Liability | $45.2M | $25.4M | $19.4M | $16.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.25B | $1.07B | $700.6M | $463.0M | $285.0M | -$31.3M | -$17.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $261.7M | $145.7M | $335.4M | $241.8M | $68.5M | $10.3M | |
| Marketable Securities Unrealized Gain Loss | $2.4M | -$90.0K | $525.0K | -$266.0K | -$228.0K | ||
| Cash And Cash Equivalents At Carrying Value | $261.7M | $145.7M | $335.4M | $241.8M | $68.5M | $10.3M | $3.0M |
| Retained Earnings Accumulated Deficit | -$972.4M | -$547.1M | -$286.3M | -$160.1M | -$78.2M | -$31.9M | |
| Liabilities Current | $91.2M | $54.0M | $31.8M | $19.5M | $8.8M | $4.4M | |
| Liabilities And Stockholders Equity | $1.41B | $1.14B | $732.4M | $482.5M | $293.8M | $10.6M | |
| Liabilities | $164.4M | $72.0M | $31.8M | $19.5M | $8.8M | $6.6M | |
| Assets Current | $1.39B | $1.13B | $726.5M | $478.0M | $290.6M | $10.6M | |
| Assets | $1.41B | $1.14B | $732.4M | $482.5M | $293.8M | $10.6M | |
| Additional Paid In Capital Common Stock | $2.22B | $1.62B | $986.8M | $623.5M | $363.5M | $842.0K | |
| Accounts Payable Current | $30.2M | $5.2M | $9.3M | $7.2M | $2.9M | $1.3M | |
| Prepaid Expense And Other Assets Current | $20.5M | $14.1M | $6.6M | $5.8M | $2.5M | $314.0K | |
| Marketable Securities Current | $1.11B | $972.6M | $384.5M | $230.4M | $219.6M | $0.00 | |
| Other Assets Noncurrent | $20.3M | $9.3M | $5.9M | $4.5M | $3.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.4M | -$59.0K | $31.0K | -$494.0K | -$228.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $116.1M | -$189.7M | $93.6M | $173.3M | $58.2M | ||
| Amortization Of Debt Discount Premium | -$14.7M | -$10.1M | -$373.0K | $215.0K | |||
| Accrued Liabilities Current | $48.8M | $22.5M | $12.3M | $5.9M | $1.2M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Liabilities Fair Value Adjustment | -$55.2M | -$17.9M | $0.00 | $0.00 | |||
| Change In Fair Value Of Preferred Stock Tranche Rights | $0.00 | $635.0K | -$2.4M | ||||
| Equity Adjustment Promissory Note Interest | -$4.0K | -$5.0K | |||||
| Gains Losses On Extinguishment Of Debt | -$580.0K | ||||||
| Temporary Equity Issue Period Increase Or Decrease | $2.6M | -$1.2M | |||||
| Equity Issuance Costs Incurred But Not Yet Paid | $336.0K | $6.0K | $0.00 | $90.0K | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $798.0K | $0.00 | $0.00 | ||||
| Settlement Of Notes Payable And Accrued Interest For Preferred Stock | $2.2M | ||||||
| Other Liabilities Noncurrent | $35.0K | $0.00 | |||||
| Cash And Cash Equivalents Period Increase Decrease | $58.2M | $7.3M | |||||
| Accrued Liabilities And Other Liabilities | $61.0M | $48.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $845.4M | $939.7M | $1.01B | $1.12B | $637.0M | $675.0M | $396.0M | $421.2M | $444.0M | $236.6M | $253.0M | $268.9M | $301.1M | -$47.7M | -$38.6M | -$24.8M | -$20.1M | -$11.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $115.8M | $127.5M | $120.8M | $369.2M | $77.7M | $98.5M | $88.4M | $70.9M | $90.1M | $76.3M | $75.9M | $67.3M | $245.9M | $138.9M | $14.4M | |||
| Marketable Securities Unrealized Gain Loss | $1.0M | $509.0K | $913.0K | $2.9M | -$253.0K | -$1.3M | $227.0K | -$1.2M | $192.0K | $266.0K | -$113.0K | -$791.0K | -$23.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $115.8M | $127.5M | $120.8M | $369.2M | $77.7M | $98.5M | $88.4M | $70.9M | $90.1M | $76.3M | $75.9M | $67.3M | $245.9M | $138.9M | $15.3M | $9.3M | ||
| Retained Earnings Accumulated Deficit | -$853.7M | -$731.3M | -$631.6M | -$472.3M | -$387.9M | -$330.8M | -$248.0M | -$214.4M | -$185.3M | -$134.0M | -$114.2M | -$95.8M | -$60.9M | -$48.5M | ||||
| Liabilities Current | $89.2M | $75.1M | $75.0M | $51.1M | $38.2M | $33.4M | $29.1M | $20.8M | $17.0M | $13.0M | $10.0M | $8.1M | $6.8M | $5.8M | ||||
| Liabilities And Stockholders Equity | $979.9M | $1.04B | $1.11B | $1.19B | $675.2M | $708.5M | $425.1M | $441.9M | $461.0M | $249.6M | $263.0M | $277.0M | $308.0M | $143.5M | ||||
| Liabilities | $134.5M | $100.8M | $94.7M | $67.7M | $38.2M | $33.4M | $29.1M | $20.8M | $17.0M | $13.0M | $10.0M | $8.1M | $6.8M | $5.8M | ||||
| Assets Current | $956.9M | $1.02B | $1.09B | $1.18B | $666.3M | $699.5M | $419.8M | $437.0M | $456.3M | $245.2M | $258.8M | $274.5M | $305.1M | $139.3M | ||||
| Assets | $979.9M | $1.04B | $1.11B | $1.19B | $675.2M | $708.5M | $425.1M | $441.9M | $461.0M | $249.6M | $263.0M | $277.0M | $308.0M | $143.5M | ||||
| Additional Paid In Capital Common Stock | $1.70B | $1.67B | $1.64B | $1.59B | $1.03B | $1.01B | $645.3M | $637.0M | $629.5M | $371.4M | $368.4M | $365.7M | $362.1M | $1.1M | ||||
| Accounts Payable Current | $22.0M | $13.3M | $26.2M | $15.9M | $7.4M | $13.4M | $9.8M | $8.1M | $6.4M | $4.6M | $4.0M | $4.2M | $2.5M | $3.8M | ||||
| Prepaid Expense And Other Assets Current | $13.8M | $14.0M | $13.3M | $11.4M | $8.3M | $7.7M | $6.5M | $5.8M | $5.8M | $5.2M | $1.9M | $1.7M | $2.7M | |||||
| Marketable Securities Current | $827.4M | $878.1M | $952.4M | $799.1M | $580.3M | $593.3M | $324.8M | $360.4M | $360.3M | $163.8M | $181.0M | $205.5M | $56.5M | |||||
| Other Assets Noncurrent | $23.0M | $20.9M | $19.3M | $9.2M | $9.0M | $9.0M | $5.3M | $5.0M | $4.7M | $4.3M | $4.2M | $2.6M | $2.8M | $2.5M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.4M | $1.4M | $854.0K | $1.4M | -$1.6M | -$1.3M | -$1.3M | -$1.5M | -$302.0K | -$866.0K | -$1.1M | -$1.0M | -$23.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$24.9M | -$236.9M | -$151.7M | -$1.3M | ||||||||||||||
| Amortization Of Debt Discount Premium | -$4.3M | -$3.4M | -$2.5M | $276.0K | ||||||||||||||
| Accrued Liabilities Current | $35.2M | $30.8M | $20.0M | $19.3M | $12.7M | $10.6M | $8.4M | $6.0M | $3.9M | $4.3M | $2.0M | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Liabilities Fair Value Adjustment | -$19.8M | -$6.0M | -$1.4M | -$16.6M | $0.00 | $0.00 | $0.00 | |||||||||||
| Change In Fair Value Of Preferred Stock Tranche Rights | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $635.0K | $724.0K | $4.5M | ||||||||||
| Equity Adjustment Promissory Note Interest | -$2.0K | -$2.0K | -$2.0K | -$1.0K | ||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$580.0K | |||||||||||||||||
| Temporary Equity Issue Period Increase Or Decrease | $2.6M | |||||||||||||||||
| Equity Issuance Costs Incurred But Not Yet Paid | ||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $798.0K | $0.00 | ||||||||||||||||
| Settlement Of Notes Payable And Accrued Interest For Preferred Stock | $2.2M | |||||||||||||||||
| Other Liabilities Noncurrent | $140.0K | $244.0K | $345.0K | |||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.3M | $4.1M | ||||||||||||||||
| Accrued Liabilities And Other Liabilities | $67.1M | $61.8M | $48.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $86.5M | $60.6M | $25.6M | $10.3M | $3.6M | $729.0K |
| Net Cash Provided By Used In Operating Activities | -$275.2M | -$185.1M | -$99.7M | -$65.0M | -$40.0M | -$14.9M |
| Net Cash Provided By Used In Financing Activities | $515.3M | $568.9M | $336.8M | $248.9M | $318.2M | $22.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $6.3M | $7.6M | -$644.0K | $1.5M | $251.0K | $14.0K |
| Increase Decrease In Accounts Payable | $24.6M | -$4.0M | $2.2M | $4.2M | $1.6M | $529.0K |
| Increase Decrease In Other Operating Assets | $10.5M | $3.4M | $1.4M | $1.3M | $3.2M | |
| Net Cash Provided By Used In Investing Activities | -$124.1M | -$573.5M | -$143.5M | -$10.7M | -$220.0M | |
| Payments To Acquire Marketable Securities | $1.06B | $1.02B | $459.5M | $212.9M | $221.0M | |
| Increase Decrease In Accrued Liabilities | $26.9M | $9.6M | $5.5M | $3.7M | $752.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $933.7M | $451.4M | $316.0M | $202.3M | $1.0M | |
| Payments Of Stock Issuance Costs | $382.0K | $483.0K | $856.0K | $644.0K | $3.0M | |
| Proceeds From Issuance Of Common Stock | $515.7M | $570.0M | $338.5M | $250.5M | $177.3M | |
| Proceeds From Stock Options Exercised | $13.8M | $1.8M | $12.0K | $15.0K | ||
| Proceeds From Issuance Of Convertible Preferred Stock | $144.7M | $22.5M | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $11.5M | $26.9M | $9.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $20.4M | $13.9M | $5.4M | $2.2M | $65.0K |
| Net Cash Provided By Used In Operating Activities | -$54.8M | -$36.1M | -$24.4M | -$13.5M | -$5.9M |
| Net Cash Provided By Used In Financing Activities | $4.5M | $6.0M | -$17.0K | -$768.0K | $10.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$818.0K | $1.1M | $3.0K | -$778.0K | $47.0K |
| Increase Decrease In Accounts Payable | $20.9M | $4.1M | -$672.0K | $1.4M | $197.0K |
| Increase Decrease In Other Operating Assets | $9.2M | $3.1M | $228.0K | -$630.0K | $398.0K |
| Net Cash Provided By Used In Investing Activities | $25.4M | -$206.8M | -$127.3M | $13.1M | $0.00 |
| Payments To Acquire Marketable Securities | $277.2M | $283.0M | $187.9M | $13.9M | |
| Increase Decrease In Accrued Liabilities | -$2.1M | -$1.2M | -$1.2M | $402.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $302.6M | $76.2M | $60.7M | $27.0M | $0.00 |
| Payments Of Stock Issuance Costs | $6.0K | $0.00 | $90.0K | ||
| Proceeds From Issuance Of Common Stock | $4.6M | $6.5M | $619.0K | ||
| Proceeds From Stock Options Exercised | $619.0K | $13.0K | |||
| Proceeds From Issuance Of Convertible Preferred Stock | $10.0M | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$373.0K | -$2.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 72.7M | 66.4M | 58.2M | 49.7M | 21.8M | 2.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 72.7M | 66.4M | 58.2M | 49.7M | 21.8M | 2.9M |
| Earnings Per Share Diluted | $-5.85 | $-3.93 | $-2.17 | $-1.65 | $-2.13 | $-5.08 |
| Earnings Per Share Basic | $-5.85 | $-3.93 | $-2.17 | $-1.65 | $-2.13 | $-5.08 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 72.1M | 71.8M | 71.6M | 65.7M | 64.6M | 64.2M | 57.1M | 56.9M | 56.7M | 48.4M | 48.3M | 48.3M | 32.1M | 3.1M | 3.1M | 3.0M | 3.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 72.1M | 71.8M | 71.6M | 65.7M | 64.6M | 64.2M | 57.1M | 56.9M | 56.7M | 48.4M | 48.3M | 48.3M | 32.1M | 3.1M | 3.1M | 3.0M | 3.0M |
| Earnings Per Share Diluted | $-1.70 | $-1.39 | $-1.18 | $-1.28 | $-0.88 | $-0.69 | $-0.59 | $-0.51 | $-0.44 | $-0.41 | $-0.38 | $-0.36 | $-0.39 | $-3.17 | $-2.20 | $-1.57 | $-2.82 |
| Earnings Per Share Basic | $-1.70 | $-1.39 | $-1.18 | $-1.28 | $-0.88 | $-0.69 | $-0.59 | $-0.51 | $-0.44 | $-0.41 | $-0.38 | $-0.36 | $-0.39 | $-3.17 | $-2.20 | $-1.57 | $-2.82 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $86.5M | $60.6M | $25.6M | $10.3M | $3.6M | $729.0K |
| Stock Issued During Period Value Stock Options Exercised | $28.8M | $13.8M | $1.8M | $12.0K | $15.0K | |
| Repayments Of Insurance Costs Financed By Third Party | $0.00 | $622.0K | $777.0K | $910.0K | $976.0K | |
| Interest And Other Income Expense | $44.7M | $38.3M | $23.3M | $4.3M | ||
| Insurance Premium Financed By Third Party | $0.00 | $0.00 | $1.4M | $1.8M | $2.0M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.2M | $652.0K | $387.0K | |||
| Stock Issued During Period Value New Issues | $471.8M | $540.0M | $323.5M | $247.9M | $174.3M | |
| Interest And Other Income | $4.3M | $114.0K | ||||
| Stock Issued During Period Shares Stock Options Exercised | 1.7M | 1.5M | 1.2M | 476.0K | 13.5K | |
| Received In Kind Interest | $4.0K | $5.0K | ||||
| Interest And Other Income Expense Net | ||||||
| Other Noncash Income Expense | -$345.0K | $0.00 | $0.00 | |||
| Stock Issued During Period Value Stock Options Exercised Restricted Stock Award Gross | $42.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $22.3M | $22.1M | $20.4M | $15.5M | $15.1M | $13.9M | $6.9M | $5.8M | $5.4M | $2.7M | $2.4M | $2.2M | $1.4M | $725.0K | $65.0K | $35.0K | $29.0K | $623.0K |
| Stock Issued During Period Value Stock Options Exercised | $10.0M | $4.0M | $6.5M | $1.4M | $1.5M | $619.0K | $394.0K | $200.0K | $13.0K | |||||||||
| Repayments Of Insurance Costs Financed By Third Party | $0.00 | $466.0K | $546.0K | $781.0K | ||||||||||||||
| Interest And Other Income Expense | $10.2M | $11.1M | $11.8M | $8.6M | $8.2M | $8.5M | ||||||||||||
| Insurance Premium Financed By Third Party | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $490.0K | $292.0K | $193.0K | |||||||||||||||
| Stock Issued During Period Value New Issues | $540.1M | $174.3M | ||||||||||||||||
| Interest And Other Income | $5.1M | $5.0M | $5.0M | $672.0K | $267.0K | $139.0K | ||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 217.9K | 425.7K | ||||||||||||||||
| Received In Kind Interest | $2.0K | |||||||||||||||||
| Interest And Other Income Expense Net | $8.6M | $8.2M | $8.5M | $5.1M | $5.0M | $5.0M | ||||||||||||
| Other Noncash Income Expense | -$32.0K | $0.00 | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised Restricted Stock Award Gross | $4.8M | $5.3M | $4.6M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.